It's funny you bring up the capital raise Wasteland because I've been thinking about that lately and was about to post this prior to your post, but got distracted.. But I'm back, so here it is;
You know.. I have been wondering lately if the reason Ilse Treurnitch owns next to no shares is because some or all of the 50 million financing will be through TwinRiver Capital. She owns next to no shares of Zen to prevent a conflict of interest which I looked into a long time ago. Maybe it was planned that way from the beginning. It's the long term financial relationship she see's between TRC and Zen. Idk, but I think there's a reason she makes a pretty big salary (bigger then GF as far as I can tell) but has no skin in the game. If anyone hasn't checked out TwinRiver Capital you probably should.
Ilse Treurnicht
PositionIndependent Director
Tenure1.9yrs
Ageno data
Compensation (per year)CA$453.13k
Company Ownership0.0015 %CA$ 1.7k 1.5k shares
Ilse Treurnicht’s career spans scientific research and commercialization, building health and cleantech firms, venture and impact capital, and public policy. She is managing partner of TwinRiver Capital (an impact investment firm), a general partner at North South Ventures (a seed stage med fund), chair of the Public Policy Forum and a director of the Equality Fund.
Ilse was CEO of MaRS Discovery District in Toronto from 2005-2017 as it developed from a nascent organization into a leading urban innovation hub. She joined MaRS from her role as CEO of Primaxis Technology Ventures, a seed stage venture capital firm (1999-2005).
She was chair of the Canadian Task Force on Social Finance (2010), served on the Government of Canada’s Science, Technology and Innovation Council (2014-2016), Canada’s Advisory Council on Economic Growth (2016-2019), and the Advisory Committee on Open Banking (2018-2021), as well as the boards of several technology firms and non-profit organizations.
Ilse holds a doctorate in chemistry from Oxford University, which she attended as a Rhodes Scholar. |
